Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy

2 May 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Prostate Cancer Treatment and Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33934205
DOI: 10.1007/s00262-021-02923-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomyPMID 33934205Read ↗

Construction and validation of an immune gene pair signature to predict biochemical recurrence of prostate cancerSemantic proximity Read ↗

A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA databaseSemantic proximity Read ↗

Identification and validation of a prognostic 5-protein signature for biochemical recurrence following radical prostatectomy in prostate cancerSemantic proximity Read ↗

5 Gleason score-associated gene signatures serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate AdenocarcinomaSemantic proximity Read ↗

Development of a Novel Immune-Related Prognostic Signature for Prostate CancerSemantic proximity Read ↗

A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate CancerSemantic proximity Read ↗

Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate CancerSemantic proximity Read ↗

Gene expression profiling predicts clinical outcome of prostate cancerSemantic proximity Read ↗

An anoikis-related gene signature for prediction of the prognosis in prostate cancerSemantic proximity Read ↗

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate CancerSemantic proximity Read ↗

Integrating Radiosensitivity Gene Signature Improves Prostate Cancer Outcome PredictionSemantic proximity Read ↗

Developing an immune‐related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.